Search hospitals > Alberta > CALGARY
Foothills Medical Centre
Claim this profileCALGARY, Alberta T2N 2T9
Global Leader in Stroke
Global Leader in Wounds and Injuries
Conducts research for Sclerosis
Conducts research for Multiple Sclerosis
Conducts research for Atrial Fibrillation
229 reported clinical trials
32 medical researchers
Summary
Foothills Medical Centre is a medical facility located in CALGARY, Alberta. This center is recognized for care of Stroke, Wounds and Injuries, Sclerosis, Multiple Sclerosis, Atrial Fibrillation and other specialties. Foothills Medical Centre is involved with conducting 229 clinical trials across 325 conditions. There are 32 research doctors associated with this hospital, such as Prism Schneider, MD, William Kent, MD, James White, MD, and Wissam Alburaki, MD.Top PIs
Prism Schneider, MDFoothills Medical Centre5 years of reported clinical research
Studies Broken Bones
Studies Wounds and Injuries
9 reported clinical trials
13 drugs studied
William Kent, MDUniversity of California, San Diego3 years of reported clinical research
Studies Broken Bones
Studies Femur Fractures
6 reported clinical trials
10 drugs studied
James White, MDFoothills Medical Centre7 years of reported clinical research
Studies Pulmonary Arterial Hypertension
Studies Coronavirus
3 reported clinical trials
8 drugs studied
Wissam Alburaki, MDFoothills Medical Centre5 years of reported clinical research
Studies Very Low Birthweight
Studies Low Birth Weight
3 reported clinical trials
3 drugs studied
Clinical Trials running at Foothills Medical Centre
Stroke
Blood Clot
Pneumonia
Traumatic Brain Injury
Lymphoma
Delirium
Post-Thrombotic Syndrome
Opioid Use Disorder
Deep Vein Thrombosis
Lymphoid Leukemia
Blood Thinners
for Atrial Fibrillation
This trial is testing whether taking blood-thinning pills can prevent strokes and other heart issues in patients who have temporary irregular heartbeats and are at risk of stroke after surgery. These pills are a recent breakthrough in preventing strokes.
Recruiting3 awards Phase 44 criteria
Asundexian
for Stroke Prevention
This trial is testing asundexian, a new medicine that prevents blood clots, in people who had a non-heart-related stroke or high-risk mini-stroke. The goal is to see if it works better at reducing future strokes without increasing bleeding risks. Asundexian is developed by Bayer AG and might prevent thrombosis without increasing bleeding.
Recruiting1 award Phase 3
Left Atrial Appendage Exclusion
for Stroke Prevention
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Recruiting1 award N/A2 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Foothills Medical Centre?
Foothills Medical Centre is a medical facility located in CALGARY, Alberta. This center is recognized for care of Stroke, Wounds and Injuries, Sclerosis, Multiple Sclerosis, Atrial Fibrillation and other specialties. Foothills Medical Centre is involved with conducting 229 clinical trials across 325 conditions. There are 32 research doctors associated with this hospital, such as Prism Schneider, MD, William Kent, MD, James White, MD, and Wissam Alburaki, MD.